YolTech to Present at The 2nd CRISPR Medicine Conference

Representative from YolTech Therapeutics will attend The 2nd CRISPR Medicine Conference in Copenhagen, Denmark, April 7-11, 2025. The Scientific Conference will include both a virtual event and an in-person event and will include talks by 60+ reputable speakers from academia and industry, bringing the global CRISPR Medicine community to the forefront, with a focus on the most critical topics in the therapeutic gene-editing field: Tools, Delivery, Safety, Functional Genomics, Standards and Regulations, Pre-clinical Research and Clinical Trials.

Dr. Zi Jun (Emma) Wang, Co-Founder, Chief Development Officer (CDO), and Chief Technology Officer (CTO) of YolTech Therapeutics, will attend the conference as a virtual speaker on April 7, 2025 (15:00-18:00 CET). She will present the latest advancements in clinical trial from YolTech Therapeutics.